M. Bachvarova

发表

Strong cytotoxic effect of the bradykinin antagonist BKM‐570 in ovarian cancer cells – analysis of the molecular mechanisms of its antiproliferative action

A. Mes-Masson, J. Stewart, D. Bachvarov, 2010, The FEBS journal.

In vivo DNase I-mediated footprinting analysis along the human bradykinin B1 receptor (BDKRB1) gene promoter: evidence for cell-specific regulation.

D. Bachvarov, R. Drouin, A. Usheva, 2005, The Biochemical journal.

Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans.

D. Bachvarov, F. Marceau, N. Brown, 2000, American journal of hypertension.

In vivo protein‐DNA interactions at the kinin B1 receptor gene promoter: No modification on interleukin‐1 beta or lipopolysaccharide induction

D. Bachvarov, R. Drouin, F. Marceau, 2000, Journal of cellular biochemistry.

Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes

J. Schanstra, D. Bachvarov, J. Pesquero, 2006, Biological chemistry.

Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.

B. Têtu, D. Bachvarov, M. Plante, 2006, International journal of oncology.

Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit.

D. Bachvarov, F. Marceau, J. Larrivée, 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

Results Vascular Contractility Mediated by B 2 R in Rabbit Jugular Vein

D. Bachvarov, F. Marceau, J. Larrivée, 2000 .

Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit.

D. Bachvarov, F. Marceau, J. Larrivée, 1999, The American journal of physiology.

Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit

D. Bachvarov, F. Marceau, S. St.-Pierre, 1999, British journal of pharmacology.

Gene expression profiling in the remnant kidney model of wild type and kinin B1 and B2 receptor knockout mice.

J. Schanstra, D. Bachvarov, J. Bascands, 2007, Kidney international.

Characterization of a polymorphism in the coding region of the human C5a anaphylatoxin receptor

D. Bachvarov, F. Marceau, J. Bergeron, 1999, Immunogenetics.

Molecular determinants of LPS-induced acute renal inflammation: Implication of the kinin B1 receptor.

J. Schanstra, D. Bachvarov, J. Bascands, 2009, Biochemical and biophysical research communications.

Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.

C. Le Page, A. Mes-Masson, D. Huntsman, 2013, Biopreservation and biobanking.

Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients.

D. Bachvarov, F. Marceau, P. Maheux, 2002, Canadian journal of physiology and pharmacology.

A study of solvates of copper(II) chloride in mixed solvents by a kinetic method

M. Bachvarova, B. G. Zhelyazkova, 1985 .

BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism

C. Guillemette, B. Vanderhyden, D. Bachvarov, 2015, Oncotarget.

Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy

D. Bachvarov, J. Masson, M. Plante, 2020, Journal of Translational Medicine.

Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.

A. Mes-Masson, D. Bachvarov, E. Paquet, 2013, Gynecologic oncology.

The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion

D. Bachvarov, M. Plante, X. Trinh, 2013, Cell cycle.

The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.

D. Bachvarov, E. Paquet, C. Garand, 2008, The international journal of biochemistry & cell biology.

Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.

D. Bachvarov, M. Plante, J. Grégoire, 2017, International journal of oncology.

Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells

D. Bachvarov, S. Gobeil, M. Plante, 2017, Cell cycle.

Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation

D. Bachvarov, M. Plante, J. Grégoire, 2014, Oncotarget.

Inhibition of RUNX2 Transcriptional Activity Blocks the Proliferation, Migration and Invasion of Epithelial Ovarian Carcinoma Cells

D. Bachvarov, S. Gobeil, M. Plante, 2013, PloS one.

A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation.

D. Bachvarov, M. Plante, J. Grégoire, 2012, Gynecologic oncology.

Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer

I. Bairati, D. Bachvarov, M. Plante, 2011, Molecular oncology.

Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids

A. Mes-Masson, D. Bachvarov, M. Bachvarova, 2008, BMC Genomics.

The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells

B. Vanderhyden, D. Bachvarov, S. Gobeil, 2016, Oncotarget.

Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner

B. Vanderhyden, D. Bachvarov, S. Gobeil, 2017, Oncotarget.

LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway

D. Bachvarov, Marie-Pier Scott-Boyer, A. Droit, 2020, International journal of molecular sciences.

Systems biology combining human- and animal-data miRNA and mRNA data identifies new targets in ureteropelvic junction obstruction

Panagiotis Moulos, Julie Klein, Joost Schanstra, 2017, BMC Systems Biology.

D. Bachvarov, J. Masson, M. Plante, 2020, Journal of translational medicine.

Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.

D. Bachvarov, F. Marceau, A. Adam, 2001, The Journal of pharmacology and experimental therapeutics.

Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas

I. Bairati, D. Bachvarov, M. Plante, 2008, Modern Pathology.

The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression

B. Vanderhyden, D. Bachvarov, S. Gobeil, 2019, International journal of molecular sciences.

Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy.

Bernard Têtu, Magdalena Bachvarova, Dimcho Bachvarov, 2006, International journal of oncology.

Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.

D. Bachvarov, F. Marceau, J. Larrivée, 2000, Hypertension.

The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression

B. Vanderhyden, D. Bachvarov, S. Gobeil, 2019, International journal of molecular sciences.

The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion

D. Bachvarov, M. Plante, X. Trinh, 2013, Cell cycle.